Back to dashboard
Episode 343
DIP Episode 343 - Paraneoplastic Syndromes and The USMLEs (Step 1-3)
MixedMedium4 - HighHas Q&A
Step 1Step 2Step 3MedicineUSMLEStep 1Step 2Step 3
Topic
Paraneoplastic syndromes; endocrine paraneoplastics (SIADH, hypercalcemia); neuromuscular and CNS manifestations of malignancy.
Key Takeaway
The USMLEs test the ability to link specific malignancies (e.g., SCLC, Multiple Myeloma) to distinct paraneoplastic syndromes (e.g., SIADH, PTHrP-mediated hypercalcemia, anti-Hu antibodies), requiring recognition of unique clinical and lab findings.
Runtime: 30.5 min
Published: 2021-09-29
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: HEME-ONC, SPECIAL TOPICS/RISK FACTORS
Episode Notes
Source / episode info
- Episode: 343
- Title: Divine Intervention Episode 343 – Paraneoplastic Syndromes and The USML Es (Step 1-3)
- Published: 2021-09-29
- Source: Episode page
One-liner
This episode provides a high-yield review of classic paraneoplastic syndromes, covering endocrine (SIADH, PT HrP hypercalcemia), neuromuscular (Myasthenia gravis/Thymoma, Anti-Jo-1 myositis), and CNS manifestations (Limbic Encephalitis, PCD) associated with various malignancies.
High-yield summary
- Small Cell Lung Cancer (SCLC): Classically associated with Syndrome of Inappropriate ADH secretion (SIADH) leading to hyponatremia and concentrated urine (>1.012 SG). It can also cause ACTH excess, leading to Cushingoid features.
- Hypercalcemia Syndromes: PT HrP production (often from Squamous Cell Lung Cancer) causes hypercalcemia; Multiple Myeloma causes it via IL-6/osteoclast activation. Both require differentiation based on associated findings and PTH levels.
- Neuromuscular Junction: Thymomas are the most common cause of paraneoplastic Myasthenia Gravis, often presenting with signs of Superior Vena Cava (SVC) syndrome.
- CNS Paraneoplastics: Anti-Yo antibodies are strongly associated with Paraneoplastic Cerebellar Degeneration (PCD). Limbic Encephalitis can be linked to SCLC (Anti-Hu) or Germ Cell Tumors (Anti-Ma2), presenting with fever, headache, and neuropsychiatric symptoms.
- Specific Syndromes: Glucagonoma causes Necrolytic Migratory Erythema (NME); Carcinoid syndrome involves flushing, diarrhea, and cardiac valvulitis due to serotonin excess; Sweet Syndrome presents with tender neutrophilic skin lesions in the context of hematologic malignancy.
Learning objectives
- Differentiate between various paraneoplastic syndromes based on associated malignancies and specific biomarkers/antibodies.
- Understand the pathophysiology of SIADH, PT HrP hypercalcemia, and other endocrine paraneoplastics.
- Recognize the clinical presentation and diagnostic workup for neuromuscular (MG) and CNS (Limbic Encephalitis, PCD) paraneoplastic processes.
- Correlate specific skin findings (e.g., NME, Canthorasis Migratoria) with underlying GI or endocrine malignancies.
- Master the differential diagnosis of hypercalcemia in malignancy (PT HrP vs Multiple Myeloma).
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Small Cell Lung Cancer | Hyponatremia, concentrated urine (>1.012 SG) | SIADH; Anti-Hu antibodies (Limbic Encephalitis) | Remember the "S" associations: SCLC -> SIADH & Serotonin/Anti-Hu. |
| Multiple Myeloma | Hypercalcemia, low PTH | IL-6 mediated osteoclast activation | Unlike PT HrP, MM causes hypercalcemia via plasma cell activity, not primary hormone mimicry. |
| Thymoma | SVC Syndrome; Ptosis/Diplopia (MG) | Anterior mediastinum | Always consider thymoma as a cause of MG and SVC syndrome when presented with these signs. |
| Paraneoplastic Cerebellar Degeneration | Ataxia, Nystagmus, Dysarthria; Anti-Yo antibodies | Any underlying malignancy (often occult) | The onset is often before the cancer diagnosis, making it tricky to link initially. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| SIADH | Hyponatremia; Urine SG > 1.012 | SCLC (most common); ADH excess | High-yield association for smoking history/encephalopathy. |
| Hypercalcemia | PT HrP vs MM vs Primary Hyperparathyroidism | Squamous Cell Lung Cancer vs Multiple Myeloma | Must differentiate the source and mechanism of hypercalcemia in malignancy. |
| Myasthenia Gravis | Ptosis, Diplopia, Worsens with effort/better with rest | Thymoma (anterior mediastinum) | The classic triad: MG symptoms + thymic mass/history. |
| Limbic Encephalitis | Fever, Headache, Psychosis; Anti-Hu / Anti-Ma2 | SCLC (Anti-Hu); Germ Cell Tumor (Anti-Ma2) | Differentiating the specific antibody based on the underlying cancer type is critical. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient with a history of smoking, acute encephalopathy, hyponatremia, and highly concentrated urine (>1.012 SG). | SIADH (Syndrome of Inappropriate ADH) secondary to SCLC | SCLC is the classic malignancy association; high ADH leads to free water retention and low serum osmolality/Na+. |
| A patient with a history of squamous cell lung cancer presents with hypercalcemia, polyuria, polydipsia, and normal PTH. | PT HrP-mediated Hypercalcemia | Squamous Cell Lung Cancer is the classic source; PT HrP mimics PTH action on bone/kidney, causing high Ca++ but low PTH. |
| A young woman develops progressive weakness of facial muscles, ptosis, and difficulty swallowing, following diagnosis of a thymoma. | Myasthenia Gravis (MG) secondary to Thymoma | MG is the most common neuromuscular paraneoplastic syndrome; thymus pathology is key for diagnosis/treatment. |
| A patient with an abdominal mass presents with opsoclonus-myoclonic signs, and imaging shows calcified masses crossing the midline in the posterior fossa. | Neuroblastoma | The combination of location (posterior fossa), appearance (calcification), and pattern (crossing midline) is pathognomonic for neuroblastoma. |
| A patient develops fever, headache, and fluctuating mental status, with anti-Hu antibodies detected, following a history of SCLC. | Limbic Encephalitis | Anti-Hu antibodies are the most common paraneoplastic antibody associated with SCLC; symptoms are neuropsychiatric/encephalopathic. |
| A man presents with progressive ataxia, nystagmus, and dysarthria months before any cancer diagnosis is made, and anti-Yo antibodies are positive. | Paraneoplastic Cerebellar Degeneration (PCD) | Anti-Yo is the key antibody; PCD often precedes the primary malignancy by a significant period. |
Differential diagnosis / distinguishing features
Neurological Syndromes
| Key Features | Distinguishing Findings | Next Step |
| Paraneoplastic Cerebellar Degeneration (PCD) | Ataxia, Nystagmus, Dysarthria; Anti-Yo antibodies positive. | Rule out other causes of ataxia (e.g., B1 deficiency); screen for occult malignancy. |
| Limbic Encephalitis | Fever, Headache, Psychosis/Memory deficits; Anti-Hu or Anti-Ma2 antibodies. | IV Ig and Plasma Exchange are primary treatments; treat the underlying cancer aggressively. |
| Opsoclonus-Myoclonic Syndrome (OMS) | Flashing eye movements (opsoclonus) + Myoclonic jerks; associated with Neuroblastoma/Teratoma. | Imaging of abdomen for neuroblastoma; monitor and manage symptoms. |
Skin Lesions
| Key Features | Distinguishing Findings | Next Step |
| Necrolytic Migratory Erythema (NME) | Red, painful lesions that appear and disappear in a migratory pattern; associated with Glucagonoma. | Measure serum glucagon levels; screen for GI tract adenocarcinoma. |
| Canthorasis Migratoria | Thickened, hyperpigmented skin patches on axilla/neck; associated with Gastric Adenocarcinoma. | Endoscopy/Colonoscopy to rule out gastric or colorectal malignancy. |
Management pearls
- For suspected SIADH in the setting of SCLC: Treat the underlying cancer first. Fluid restriction and careful monitoring are key, as ADH excess is the primary driver.
- When managing Limbic Encephalitis: Empirical treatment with IV Ig or Plasma Exchange (PLEX) should be initiated immediately while aggressively searching for the causative malignancy.
- For suspected Myasthenia Gravis secondary to Thymoma: The definitive workup includes testing for antibodies and often requires a chest CT/thymectomy, as thymoma removal can improve symptoms.
- In cases of hypercalcemia due to PT HrP (Squamous Cell Lung Cancer): Treat the underlying cancer; hydration and calcitonin may be used acutely.
Don't miss
🚨
SCLC is associated with SIADH (hyponatremia, high urine SG) AND Anti-Hu antibodies (Limbic Encephalitis).
🚨
PT HrP hypercalcemia is classically linked to Squamous Cell Lung Cancer and results in low PTH.
🚨
Neuroblastoma masses are typically calcified and cross the midline; this helps differentiate them from other abdominal masses like uterine fibroids.
🚨
The constellation of fever, headache, and neuropsychiatric symptoms (psychosis/memory loss) strongly suggests Limbic Encephalitis over simple psychosis.
Integration & clinical reasoning
- Endocrine Integration: Paraneoplastic syndromes can mimic endocrine disorders (e.g., PT HrP hypercalcemia mimicking primary hyperparathyroidism). Always check the source of the hormone excess or deficiency.
- Oncology/Neurology Integration: Many cancers (SCLC, testicular germ cell tumors) have specific paraneoplastic antibodies that target neuronal components (Anti-Hu, Anti-Ma2), linking oncology and neurology.
- GI Tract Integration: The skin findings (NME, Canthorasis Migratoria, Lesat-Trelat sign) are often the first clues pointing toward an underlying GI adenocarcinoma or endocrine tumor (Glucagonoma).
OMM / COMLEX integration
🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
- For any acute neurological presentation (e.g., status epilepticus from encephalopathy or severe ataxia): Standard emergency management (airway/breathing/circulation support) takes absolute priority over OMT.
- When considering the underlying malignancy: The diagnosis of a paraneoplastic syndrome requires aggressive oncologic workup, which is paramount for long-term prognosis and symptom resolution.
Concept connections / cross-references
- For detailed information on adrenal insufficiency workups and Cushing syndrome: Episode 315.
- For general principles of neuromuscular junction disorders and autoimmune myopathies: Episode 289.
- For comprehensive review of pituitary hormones and endocrinology: Episode 304.
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Small Cell Lung Cancer | SIADH; Anti-Hu antibodies | ADH excess (SIADH); Immune targeting neuronal tissue (Anti-Hu) | High yield association for hyponatremia and limbic encephalitis. |
| Multiple Myeloma | Hypercalcemia, Renal failure | IL-6/Osteoclast activation by plasma cells | Distinguishes hypercalcemic malignancy from PT HrP sources; often presents with bone pain/pathologic fractures. |
| Thymoma | Myasthenia Gravis (MG); SVC Syndrome | Autoimmune attack on postsynaptic acetylcholine receptors | Thymectomy is both diagnostic and therapeutic for MG. |
| Glucagonoma | Necrolytic Migratory Erythema (NME) | Glucagon excess; metabolic derangement | NME is a pathognomonic skin finding that points directly to glucagonomas. |
Key terms glossary
| Term | Definition | Context | Example |
| SIADH | Syndrome of Inappropriate ADH secretion | Hyponatremia due to excessive free water retention, often seen in SCLC. | Low serum sodium (e.g., 121 mEq/L) with concentrated urine (>1.012 SG). |
| PT HrP | Parathyroid hormone-related protein | Hormone secreted by Squamous Cell Lung Cancer; mimics PTH action. | Causes hypercalcemia and hypophosphatemia, but PTH levels remain low. |
| Opsoclonus-Myoclonic Syndrome (OMS) | Flashing eye movements (opsoclonus) combined with myoclonic jerks. | Associated with Neuroblastoma or Teratoma; a paraneoplastic phenomenon. | Seen in children with abdominal masses, suggesting neuroblastoma origin. |
| Anti-Yo Antibody | Autoantibody targeting neuronal tissue components. | Paraneoplastic Cerebellar Degeneration (PCD). | High suspicion for PCD when ataxia/nystagmus are present and anti-Yo is positive. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Paraneoplastic Syndromes | Create flowcharts linking malignancy -> syndrome -> antibody/lab finding. | High (Board-level integration) | Review classic associations: SCLC, MM, Thymoma, Neuroblastoma. |
| Endocrine Paraneoplastics | Master the differential diagnosis of hypercalcemia and hyponatremia sources. | Medium-High (Step 1/2 focus) | Compare PT HrP vs. IL-6 mechanism; compare SIADH findings. |
| Neurological Syndromes | Focus on differentiating symptoms: PCD vs Limbic Encephalitis vs MG. | High (Clinical reasoning) | Use the antibodies and associated cancer types as anchors for differentiation. |
Question pattern recognition
- Pattern: Hyponatremia + Smoking History + Concentrated Urine -> SIADH secondary to SCLC. This is a classic, high-yield combination question.
- Pattern: Fever/Headache/Psychosis + Anti-Hu antibodies + SCLC history -> Limbic Encephalitis. The antibody and the underlying cancer are key.
- Pattern: Abdominal mass (calcified, crosses midline) in a child with ataxia/nystagmus -> Neuroblastoma causing Opsoclonus-Myoclonic Syndrome.
Test yourself
Common mistakes to avoid
🚫
Assuming that all paraneoplastic syndromes are caused by the same underlying cancer (e.g., assuming SCLC causes everything). The association is specific (SCLC -> SIADH; Germ Cell Tumor -> Anti-Ma2).
🚫
Confusing the mechanism of hypercalcemia: Remember PT HrP mimics PTH, while MM uses cytokine activation (IL-6) to stimulate osteoclasts.
🚫
Misinterpreting the timing of PCD: The syndrome can manifest months or years before the cancer is diagnosed, which is a critical diagnostic clue.
Common traps
⚠️
Trap 1 (SIADH): Given hyponatremia and high urine SG, students may incorrectly choose DI/adrenal insufficiency. Remember that SIADH involves ADH excess, not deficiency.
⚠️
Trap 2 (Hypercalcemia): When presented with hypercalcemia in a patient with lung cancer, always check the PTH level to distinguish between PT HrP sources (low PTH) and primary parathyroid issues (high PTH).
⚠️
Trap 3 (Limbic Encephalitis vs PCD): Limbic encephalitis presents with prominent psychiatric symptoms (psychosis, memory loss), while PCD is characterized by pure cerebellar signs (ataxia, nystagmus).